In the present study, the ability of HSPA5 to modulate alternative splicing (AS) of cellular genes was assessed using Real-Time PCR on 89 NAFLD-associated genes. The gene discussed is HSPA5; the disease is metabolic dysfunction-associated steatotic liver disease.